Germany’s Max Planck Society, the research powerhouse that includes the Max Planck Florida Institute for Neuroscience, has been ranked as the top biomedical nonprofit organization in the world by Nature Index. The rankings examine prominent research institutions and scientists across the world whose publications profoundly impact biomedical research. In addition to taking the top spot among nonprofit/NGO institutions, the Max Planck Society ranked fifth overall when compared to all research organizations, including major universities and government health agencies.
“The Max Planck Society’s unique ‘science-first’ core values create an environment for unparalleled research excellence. We are proud to be a part of the leading nonprofit research organization in the world, and to represent the Max Planck Society in the United States,” said David Fitzpatrick, CEO and Scientific Director of the Max Planck Florida Institute.
The Max Planck Florida Institute for Neuroscience is the only Max Planck Institute in North America. Besides the one in Jupiter, Florida, the Max Planck Society operates another 83 institutes, most of them in Germany, one in Luxemburg, two in Italy, and one in the Netherlands.
Since its establishment in 1948, 18 Nobel laureates have emerged from the ranks of its scientists. As its first U.S. institution, MPFI brings together exceptional neuroscientists from around the world to answer fundamental questions about brain function and development and to advance new technologies that make groundbreaking scientific discoveries possible. Their research is shared publicly with scholars, universities and other organizations around the globe, providing the necessary foundation of knowledge to develop treatments and cures for brain disorders such as autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.